Vivani Medical VANI Neurostimulation Division — Net Income Loss

Other segment segments

Similar metrics at other companies

HRMYRare Neurological Diseases — Net Income Loss

$32.49M-28.7%

LIVNNeuromodulation — Operating Income

$44.15M-15.7%

LIVNNeuromodulation — Net revenue

$151.79M+9.3%

BTCSAll Other Segments — Net Income Loss

-$69.16M-301%

BSXNeuromodulation — Net Sales

$318M+17.3%

CBANSmall Business Specialty Lending Division — Net Income Loss

$74K-81.1%

Questions, answered.

What is Vivani Medical's neurostimulation division — net income loss?

Vivani Medical (VANI) reported neurostimulation division — net income loss of -$626.5K in Q4 2025.

How has Vivani Medical's neurostimulation division — net income loss changed year-over-year?

Vivani Medical's neurostimulation division — net income loss decreased by 12.3% year-over-year, from -$558K to -$626.5K.

What is the long-term trend for Vivani Medical's neurostimulation division — net income loss?

Over 2 years (2023 to 2025), Vivani Medical's neurostimulation division — net income loss has grown at a -31.8% compound annual growth rate (CAGR), from -$5.39M to -$2.51M.

What does neurostimulation division — net income loss mean?

Measures the profitability of the neurostimulation division by subtracting all segment-specific operating and non-operating expenses from its revenues. This figure indicates whether the division is currently self-sustaining or requires capital support from the parent company. It is a primary indicator of the segment's financial health and contribution to the overall corporate bottom line.